Skip to main content

Table 2 Relationship between tumor syndecan-1 status and patient 5 year and median survival

From: Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumors

Syndecan-1
Scoring
5 yr survival
rate (%)
Median
survival
(months)
95% CI
0 38.6 43 21–97
1+ 47.7 49 16–82
2+ 52.0 83 45–121
3+ 43.7 57 5–109
\